Exelixis
EXEL
#1673
Rank
โ‚ฌ9.45 B
Marketcap
33,10ย โ‚ฌ
Share price
-0.54%
Change (1 day)
68.47%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

Stock price history for Exelixis (EXEL)

Highest end of day price: 46,76ย โ‚ฌ Euro on 2000-07-26

Lowest end of day price: 1,22ย โ‚ฌ Euro on 2014-12-24

Stock price history of Exelixis from 2000 to 2024

Stock price for similar companies or competitors

Company Stock price Change 1d% Country
31,77ย โ‚ฌ-1.58%๐Ÿ‡ฌ๐Ÿ‡ง UK
45,70ย โ‚ฌ 0.67%๐Ÿ‡ซ๐Ÿ‡ท France
92,55ย โ‚ฌ-0.89%๐Ÿ‡บ๐Ÿ‡ธ USA
53,78ย โ‚ฌ-3.16%๐Ÿ‡บ๐Ÿ‡ธ USA
267,40ย โ‚ฌ-4.82%๐Ÿ‡บ๐Ÿ‡ธ USA
146,25ย โ‚ฌ 1.43%๐Ÿ‡บ๐Ÿ‡ธ USA
23,58ย โ‚ฌ-4.53%๐Ÿ‡บ๐Ÿ‡ธ USA
3,73ย โ‚ฌ-1.26%๐Ÿ‡บ๐Ÿ‡ธ USA
14,24ย โ‚ฌ 0.00%๐Ÿ‡บ๐Ÿ‡ธ USA